Charcot triad and Reynolds pentad constitute the hallmark clinical syndromes associated with acute cholangitis, a potentially fatal infection of the biliary tree resulting from biliary stasis and luminal obstruction 1. First described by Jean-Martin Charcot in 1877, the classic triad comprises right upper quadrant abdominal pain, jaundice, and fever, which collectively reflect the presence of biliary ductal hypertension and infection 1. When this triad progresses to include hypotension and altered mental status—a severe manifestation designated as Reynolds pentad—the condition indicates suppurative cholangitis, characterized by purulent bile under high pressure within the biliary tree, rapid progression to septic shock, and a high mortality rate if prompt therapeutic intervention is delayed 1.

1. Etiology & Risk Factors

  • Choledocholithiasis: The most frequent etiology, accounting for 30% to 50% of acute cholangitis cases, where gallstones migrate from the gallbladder into the common bile duct, causing mechanical obstruction 1.
  • Benign Biliary Strictures: Post-surgical strictures (following cholecystectomy or biliary reconstruction), chronic pancreatitis, primary sclerosing cholangitis (PSC), and anastomotic strictures after liver transplantation 1.
  • Malignant Obstruction: Cholangiocarcinoma, pancreatic head adenocarcinoma, ampullary carcinoma, and extrinsic compression of the biliary tree by metastatic lymphadenopathy 1.
  • Instrumental Contamination: Iatrogenic inoculation of bacteria during diagnostic or therapeutic biliary instrumentation, including Endoscopic Retrograde Cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), or transjugular intrahepatic portosystemic shunt (TIPS) placement 1.
  • Parasitic Infestations: Biliary ascariasis, clonorchiasis, and opisthorchiasis, which are endemic in specific geographic regions and cause physical obstruction of the biliary ducts 1.
  • Stent Occlusion: Encrustation, sludge formation, or tumor ingrowth in previously placed metallic or plastic biliary stents, precipitating acute stent failure and secondary infection 1.

2. Pathophysiology

The pathophysiological sequence underlying Charcot triad and Reynolds pentad requires two simultaneous insults: elevated biliary tract pressure and bacterial contamination of the biliary tree 1. Normally, the biliary system is sterile due to the continuous downward flow of bacteriostatic bile, the bacteriostatic action of bile salts, and the mechanical barrier function of the sphincter of Oddi. When a mechanical obstruction—such as a common bile duct stone or tumor—occurs, intraductal pressure rises rapidly. Once biliary pressure exceeds normal secretory pressure (typically exceeding 20 cm $H_{2}O$), tight junctions between hepatocytes are disrupted, allowing bacteria and their toxins to reflux directly into the hepatic sinusoids and systemic circulation, resulting in bacteremia and systemic inflammatory response syndrome (SIRS). Ascending enteric bacteria—predominantly gram-negative bacilli such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, alongside enterococci—proliferate within this stagnant, nutrient-rich environment. As intraductal pressure continues to mount and purulent exudate fills the biliary tree (suppurative cholangitis), systemic vascular resistance collapses secondary to cytokine release (tumor necrosis factor-alpha, interleukin-1, and interleukin-6), culminating in septic shock, tissue hypoperfusion, and cerebral hypoxemia, thereby completing Reynolds pentad 1.

Charcot triad and Reynolds pentad — Pathophysiological Cascade & Clinical Flowchart 1 Biliary Obstruction Choledocholithiasis, benign stricture, or malignant neoplasm blocks normal bile flow 2 Bacterial Proliferation Elevated intraductal pressure compromises mucosal barrier and permits ascending infection from the duodenum 3 Systemic Bacteremia Infected bile enters the hepatic circulation, producing systemic inflammatory response syndrome (SIRS) 4 Organ Dysfunction Septic shock and altered mental status superimpose upon the classic triad to form Reynolds pentad 5 Urgent Drainage Emergency ERCP or percutaneous transhepatic cholangiography relieves intraductal pressure and clears infection

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with right upper quadrant (RUQ) or epigastric abdominal pain, intermittent or sustained fevers with shaking chills, and noticeable yellowish discoloration of the sclerae and skin (jaundice) 1. A history of biliary disease, previous gallstone attacks, recent ERCP procedures, or malignant hepatobiliary diagnoses is frequently elicited.
  • Physical Examination & Named Clinical Signs:
    • Charcot Triad: Manifests as the concurrence of RUQ tenderness, jaundice, and fever/rigors.
    • Reynolds Pentad: Adds shock (systolic blood pressure less than 90 mmHg, tachycardia, diaphoresis) and altered mental status (confusion, lethargy, or obtundation) to Charcot triad, signaling severe suppurative cholangitis requiring immediate resuscitation and decompression 1.
    • Murphy Sign: May be positive if concomitant acute cholecystitis is present, though isolated common bile duct obstruction often yields RUQ tenderness without an exquisite Murphy sign.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationEndoscopic Retrograde Cholangiopancreatography (ERCP) combined with abdominal ultrasonography showing common bile duct dilation (greater than 6-8 mm, or greater than 10 mm in post-cholecystectomy patients) and intraluminal echogenic calculi with acoustic shadowing.
Laboratory PanelLeukocytosis with a left shift (WBC greater than 12,000/mcL); conjugated hyperbilirubinemia (total bilirubin typically greater than 2 mg/dL); elevated alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT); moderate elevation of aminotransferases (AST/ALT); and elevated inflammatory markers (CRP and ESR). In severe cases, coagulopathy (elevated INR) and acute kidney injury (elevated creatinine) reflect sepsis-induced end-organ dysfunction.
Imaging / Radiology (X-ray, US, CT, MRI)Abdominal Ultrasound serves as the initial screening modality demonstrating biliary dilation and choledocholithiasis. Computed Tomography (CT) scan provides high-resolution visualization of ductal obstruction, strictures, or mass lesions. Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive alternative providing detailed visualization of the biliary tree without procedural risks when ERCP is not immediately required.
ECG / Histopathology / ProceduralElectrocardiogram (ECG) to rule out cardiac ischemia presenting as epigastric pain. Bile Gram stain and culture obtained during biliary cannulation guide targeted antimicrobial therapy. Histopathological analysis of biliary brushings or resected specimens confirms underlying malignancy or inflammatory strictures.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Tokyo Guidelines 2018 (TG18) Diagnostic CriteriaRequires at least one item from Systemic Inflammation (Fever/chills, Laboratory evidence of inflammatory response: WBC greater than 10,000/mcL or CRP greater than 1 mg/dL), one item from Cholestasis (Jaundice: total bilirubin greater than or equal to 2 mg/dL, Abnormal liver enzymes: ALP, GGT, AST, ALT elevated more than 1.5 times standard normal), and one item from Imaging (Biliary dilatation, or Evidence of etiology on imaging such as stricture, stone, or stent). Definitive diagnosis requires one item from each category.
TG18 Severity Grade III (Severe)Associated with onset of dysfunction in at least one organ system: Cardiovascular (hypotension requiring dopamine or norepinephrine), Neurological (disturbance of consciousness/altered mental status), Respiratory ($PaO_2/FiO_2$ ratio less than 300), Renal (oliguria, serum creatinine greater than 2.0 mg/dL), Hepatic (PT-INR greater than 1.5), or Hematological (thrombocytopenia: platelets less than 100,000/mcL). Requires urgent biliary drainage and intensive care unit admission.
TG18 Severity Grade II (Moderate)Associated with any two of the following conditions: Abnormal white blood cell count (greater than 12,000/mcL or less than 4,000/mcL), High fever (greater than 39°C), Age (greater than or equal to 75 years), Hyperbilirubinemia (total bilirubin greater than or equal to 5 mg/dL), Hypoalbuminemia (albumin less than lower limit of normal multiplied by 0.7). Requires early endoscopic or percutaneous biliary drainage.
TG18 Severity Grade I (Mild)Acute cholangitis that does not meet criteria for Grade II or Grade III severe disease. Responds initially to medical therapy and supportive care, with prompt elective or semi-urgent biliary drainage.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute CholecystitisFeatures RUQ pain, fever, and leukocytosis, but typically lacks prominent jaundice and common bile duct dilation. Ultrasound reveals gallstones, gallbladder wall thickening (greater than 4 mm), pericholecystic fluid, and a positive Murphy sign.
Acute PancreatitisPresents with severe epigastric pain radiating to the back, nausea, and vomiting. Serum lipase and amylase are elevated at least three times the upper limit of normal. Imaging demonstrates pancreatic inflammation and edema rather than isolated biliary ductal obstruction.
Acute HepatitisCharacterized by marked transaminase elevations (AST and ALT often exceeding 500-1,000 IU/L), moderate bilirubin elevation, and viral serology positivity. Biliary tree remains normal in caliber without mechanical ductal obstruction on ultrasound.
Liver Abscess / Pyogenic Liver InfectionPresents with fever, RUQ pain, and hepatomegaly, but jaundice is less common. Cross-sectional imaging (CT or MRI) reveals fluid-filled hepatic parenchymal lesions rather than dilated extrahepatic bile ducts.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation:
    • Establish large-bore intravenous access and initiate aggressive fluid resuscitation with isotonic crystalloids (e.g., Lactated Ringer's solution) to restore mean arterial pressure.
    • Institute continuous hemodynamic, cardiac, and pulse oximetry monitoring. Transfer patients manifesting Reynolds pentad to an intensive care unit.
    • Correct coagulopathies and thrombocytopenia using fresh frozen plasma (FFP) or platelet transfusions prior to invasive biliary instrumentation.
  • First-Line Medical / Pharmacological Therapy:
    • Administer empiric broad-spectrum intravenous antimicrobial therapy immediately after obtaining blood cultures.
    • Regimen A (Antipseudomonal Penicillin/Beta-lactamase inhibitor): Piperacillin-tazobactam 4.5 g IV every 6 hours 1.
    • Regimen B (Third-generation Cephalosporin plus Anaerobic coverage): Ceftriaxone 2 g IV every 24 hours plus Metronidazole 500 mg IV every 8 hours 1.
    • Regimen C (Fluoroquinolone-based for penicillin-allergic patients): Ciprofloxacin 400 mg IV every 12 hours plus Metronidazole 500 mg IV every 8 hours, or Levofloxacin 750 mg IV every 24 hours 1.
    • Adjust antibiotic selection based on local resistance patterns and definitive bile/blood culture sensitivities.
  • Surgical / Interventional Indications:
    • Urgent Biliary Decompression: Endoscopic Retrograde Cholangiopancreatography (ERCP) with sphincterotomy and stone extraction, balloon sweeping, or stent placement is the gold-standard procedure, ideally performed within 24 hours for moderate-to-severe cases.
    • Alternative Drainage Modalities: Percutaneous transhepatic cholangiography (PTC) and drainage if ERCP fails or is anatomically precluded (e.g., Roux-en-Y gastric bypass). Surgical common bile duct exploration and T-tube placement are reserved for refractory cases or when ERCP is unsuccessful.

8. Complications & Prognosis

  • Acute Complications: Septic shock, multiorgan dysfunction syndrome (MODS), acute respiratory distress syndrome (ARDS), acute kidney injury requiring renal replacement therapy, hepatic abscess formation, and hemobilia 1.
  • Mortality and Morbidity: While historically associated with mortality rates exceeding 50% prior to the advent of endoscopic decompression, modern management combining prompt antibiotic therapy and emergency ERCP has reduced mortality to below 10% in mild-to-moderate cases. However, mortality in patients presenting with full Reynolds pentad and septic shock remains significantly higher, ranging between 20% and 40%.
  • Prognostic Factors: Advanced age, delayed biliary decompression beyond 24-48 hours, underlying hepatobiliary malignancy, leukopenia, renal failure, and pre-existing comorbid cardiopulmonary disease are primary predictors of adverse outcomes and increased mortality 1.